[LGND] YoY Quarter Result on 31-Mar-2020 [#Q1]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
08-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -227.64%
YoY- -103.62%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Revenue 43,979 45,693 55,150 33,161 43,484 56,157 29,267 7.01%
PBT 55,536 -20,140 5,764 -30,415 842,713 55,312 6,193 44.11%
Tax 11,922 -4,755 -12,342 -6,284 176,376 10,033 1,114 48.42%
NP 41,949 -15,385 18,106 -24,131 666,337 45,279 5,079 42.15%
Tax Rate -21.47% - 214.12% - -20.93% -18.14% -17.99% -
Total Cost 2,030 61,078 37,044 57,292 -622,853 10,878 24,188 -33.81%
Ratio Analysis
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
NP Margin 95.38 -33.67 32.83 -72.77 1,532.37 80.63 17.35 32.83%
Per Share
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
EPS 2.46 -0.92 1.10 -1.46 32.59 2.13 0.24 47.35%
EPS Diluted 2.33 -0.91 1.05 -1.46 31.32 1.83 0.22 48.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.